Skip to content

Shared Online Health Records for Patient Safety and Care

Shared Online Health Records for Patient Safety and Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00251875
Enrollment
5400
Registered
2005-11-11
Start date
2005-07-31
Completion date
2007-09-30
Last updated
2005-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

patient portals, electronic health records, family history, health maintenance, medications, diabetes

Brief summary

The study uses a randomized, prospective cohort design to assess the impact of shared online health records on 1) patient safety, 2) health goal adherence and outcomes, 3) documentation of family history, and 4) barriers to the adoption of patient-physician communication technology. Hypothesis: the respective interventions will result in 1) improved patient safety 2) greater adherence to health care maintenance and chronic disease guidelines 3) more accurate documentation of family history 4) the identification of technology adoption enablers and barriers.

Detailed description

During the first phase of the study, primary care practice patients continue to receive usual care while their physician's offices are using Patient Gateway, an Internet portal offering secure messaging, common requests, chart information, and health information that has already been developed. Also in this first phase, all patients using Patient Gateway will receive an electronic letter explaining the research study and a link to an electronic consent form. In addition to recruitment of subjects, phase 1 allows for baseline data to be collected. In the second phase, study clinics will be randomized into one of two intervention arms. Study subjects whose clinics are randomized into Arm 1 will be invited to review and comment on their medication, allergy, and diabetes information through Patient Gateway; they can then submit this information to their primary care physician for review. Those randomized into Arm 2 will report on their health maintenance status and family history and submit this information to their primary care physician through Patient Gateway prior to a scheduled visit. Chart reviews performed at the end of Phase 1 and Phase 2 will be conducted to identify differences in process measures and outcome measures between intervention and control groups. In addition, a medication phone survey sub-study will be conducted to evaluate the effect of the new Patient Gateway features on medication management.

Interventions

DEVICEonline health information journal

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients, who are enrolled in Patient Gateway, of physicians and practices participating in the study.

Exclusion criteria

* Any patients who are not enrolled in Patient Gateway or do not belong to a participating practice.

Design outcomes

Primary

MeasureTime frame
1. ADEs
2. duration of ameliorable medication side effects
3. health goal adherence rates
4. diabetes outcomes
5. familial risk factor documentation rates
6. user satisfaction surveys
7. user metrics

Countries

United States

Contacts

Primary ContactAlexandra Businger
abusinger@partners.org

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026